首页 | 本学科首页   官方微博 | 高级检索  
     

30例注射用双黄连(冻干)不良反应分析及思考
引用本文:覃夏婵,黄凤林,冯剑. 30例注射用双黄连(冻干)不良反应分析及思考[J]. 中国医药科学, 2011, 0(20): 71-72
作者姓名:覃夏婵  黄凤林  冯剑
作者单位:广西壮族自治区贵港市覃塘区人民医院药剂科
摘    要:目的了解注射用双黄连(冻干)临床应用的安全性,探讨其不良反应表现,为临床使用提供参考。方法对笔者所在医院2008年6月~2010年12月使用注射用双黄连(冻干)发生不良反应的患者情况进行分类统计、分析。结果注射用双黄连(冻干)不良反应临床主要表现为全身性损害、呼吸系统损害及多器官多系统损害,程度轻重不一、预后良好。结论药品生产企业加强上市后的安全监测,并开展生产工艺和质量研究,完善药品说明书;医生、患者应严格按照药品说明书的规定合理用药,以减少药品不良反应的发生。

关 键 词:注射用双黄连(冻干)  不良反应  安全性

Analysis and reflection of 30 cases with adverse reactions of Shuanghuanglian lyophilized powder for injection
QIN Xiachan,HUANG Fenglin,FENG Jian. Analysis and reflection of 30 cases with adverse reactions of Shuanghuanglian lyophilized powder for injection[J]. China Medicine and Pharmacy, 2011, 0(20): 71-72
Authors:QIN Xiachan  HUANG Fenglin  FENG Jian
Affiliation:Department of Pharmacy, Qintang People’s Hospital of Guigang in Guangxi Zhuang Autonomous Region, Guigang 537121,China
Abstract:Objective To explore the clinical safty of Shuanghuanglian lyophilized powder for injection,and to explore its rule of ADR so as to provide reference for clinical use. Methods The ADR of Shuanghuanglian Lyophilized Powder for Injection were collected and analyzed from June,2008 to December,2010. Results The ADR of Shuanghuanglian Lyophilized Powder for Injection and mainly resulted in systemic,respieratory,multi-organ or multi-system damage.All of them have good prognosis. Conclusion Manufacturers should regula the process,prefect the directions the doctors and patents should strictly obey the direction in order to deduce the ADR.
Keywords:Shuanghuanglian lyophilized powder for injection  Adverse reactions  Safety
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号